Hap Trading, LLC Global Blood Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $6.72 Million - $14.1 Million	207,300 New	207,300 $132,000
Q1 2022 May 12, 2022	SELL	$25.68 - $35.59 $677,952 - $939,576	-26,400 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $405,870 - $656,238	16,300 Added 161.39%	26,400 $12,000
Q3 2021 Nov 10, 2021	SELL	$25.48 - $37.34 $58,604 - $85,882	-2,300 Reduced 18.55%	10,100 $5,000
Q2 2021 Aug 11, 2021	BUY	$32.46 - $43.42 $48,690 - $65,130	1,500 Added 13.76%	12,400 $12,000
Q1 2021 May 14, 2021	BUY	$38.94 - $50.85 $424,446 - $554,265	10,900 New	10,900 $15,000
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $3.12 Million - $5.29 Million	-83,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $4.38 Million - $6.18 Million	83,000 New	83,000 $43,000
Q1 2020 May 08, 2020	SELL	$41.72 - $87.2 $446,404 - $933,040	-10,700 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$45.7 - $81.86 $3.23 Million - $5.79 Million	-70,700 Reduced 86.86%	10,700 $67,000
Q3 2019 Nov 12, 2019	BUY	$45.35 - $57.91 $3.69 Million - $4.71 Million	81,400 New	81,400 $114,000
Q1 2019 May 10, 2019	SELL	$39.99 - $53.48 $4.23 Million - $5.65 Million	-105,700 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$31.54 - $46.67 $1.98 Million - $2.94 Million	62,900 Added 146.96%	105,700 $276,000
Q3 2018 Nov 09, 2018	SELL	$38.0 - $51.1 $3.99 Million - $5.37 Million	-105,000 Reduced 71.04%	42,800 $182,000
Q2 2018 Aug 13, 2018	BUY	$38.7 - $50.15 $5.72 Million - $7.41 Million	147,800 New	147,800 $828,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.